ANALYSIS OF THE DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF COVID-19 INFECTED PATIENTS WITH DIABETES MELLITUS UNDERGOING CORONARY REVASCULARIZATION

Abstract

The article presents a study aimed at examining the demographic characteristics and clinical outcomes related to COVID-19 infection in patients with diabetes mellitus (DM) who have previously undergone coronary revascularization treatment. Clinical outcomes evaluated during the pandemic period included cases of acute coronary syndrome (ACS), the need for repeat revascularization, hospital admissions, the need for mechanical ventilation during hospitalization, stroke, and mortality. The study involved 620 patients who had previously undergone coronary revascularization and were infected with COVID-19. Among them, 267 patients (43.1%) had comorbid diabetes (DM). The study showed that patients with comorbid diabetes required hospitalization more often than those without this condition: 27% (72 patients) of those with diabetes were hospitalized, compared to 15.6% (55 patients) of those without diabetes (p<0.05). Although the need for mechanical ventilation was slightly higher among diabetic patients (11.1% in diabetic patients versus 3.6% in non-diabetic patients), no statistically significant difference was found between the groups (p > 0.05). Similarly, there was no statistically significant difference in the number of cases complicated by stroke (1.1% and 2.2%, respectively) and mortality (5.7% and 5.6%) (p> 0.05). The results indicate that patients with diabetes who have undergone coronary revascularization are more challenging to treat and require a more intensive approach when they are infected with COVID-19.